Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Aktiia's Continual Blood Pressure Solution Shows Comparable Results to ABPM 2023-05-04 00:00
SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector 2023-05-03 22:43
EDAN Announces Integration with PointClickCare for Better Senior Primary Care 2023-05-03 21:56
Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic™ Clinical Trial 2023-05-03 21:00
Healthcare Veteran, Zach Henderson to lead Global Kinetics as CEO 2023-05-03 21:00
LenioBio GmbH Announces New CEO 2023-05-03 20:00
Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting 2023-05-03 12:00
Chula Researchers Develop Rapid MTB Strip Test for Tuberculosis 2023-05-03 11:34
Merck Signs MoU with Ministry of Trade, Industry & Energy and Daejeon City for New Asia Pacific BioProcessing Production Center in South Korea 2023-05-03 10:00
Sourcing Ideal Medical Device Materials: Experience ICP DAS - BMP medical-grade TPUs at 2023 CMEF Shanghai, China 2023-05-03 09:46
Completion of Enrollment in Cohorts C and G of China Phase II Clinical Study of Osemitamab (TST001) in Combination with CAPOX with or without Nivolumab as First-line Treatment of Gastric/Gastro-esophageal Junction Cancer Patients 2023-05-03 08:00
ZEISS Presents New Surgical Workflow Innovations at ASCRS 2023-05-03 02:09
Turacoz Forges Ahead with Veeva Content Certification & Training for Professionals 2023-05-03 01:55
Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis 2023-05-03 00:22
iHerb Names Miriee Chang as Chief Operating Officer 2023-05-03 00:14
Cellenkos Announces First Patient Dosed with CK0803 Cell Therapy for Treatment of Amyotrophic Lateral Sclerosis 2023-05-03 00:07
China Jo-Jo Drugstores Receives Hangzhou Municipal People's Government Quality Management Excellence Award 2023-05-02 20:30
Ascletis Announces ASC40, a First-in-Class, Once-Daily Oral FASN Inhibitor, Achieved Endpoints in Phase II Clinical Trial for Acne 2023-05-02 17:30
Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology 2023-05-02 12:01
First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide 2023-05-02 05:00
1 204 205 206 207 208 970